Abstract: Natural products play a significant role in human health in relation to the prevention and treatment of inflammatory conditions. Among them, terpenoids (also referred to as terpenes), are the largest and most widespread class of secondary metabolites. They are found in higher plants, mosses, liverworts, algae and lichens, and also in insects, microbes or marine organisms. Some terpenoids have been used for therapeutic purposes for centuries as antibacterial, antiinflammatory, antitumoral agents, and in recent decades research activity into the clinical potential of this class of compounds has increased continuously as a source of pharmacologically interesting agents. In the present review, molecular basis of the anti-inflammatory action of diterpenoids is presented with special emphasis on their ability to modulate critical cell signaling pathways involved in the inflammatory response of the body such as nuclear transcription factor-kappaB (NF-B) activation. NF-B plays an important role in the regulation of immune and inflammatory responses. Indeed, deregulated NF-B expression is a characteristic phenomenon in several inflammatory diseases and NF-B has become a major target in drug discovery. Hence, this article also introduces our recently elucidated findings about the potential of labdane diterpenoids as anti-inflammatory agents due to their ability to inhibit NF-B. The future development of this class of compounds as anti-inflammatory drugs requires the introduction of novel molecular targets of therapeutic relevance in addition to biotechnological approaches for the production of these molecules.
INTRODUCTION
Inflammation is the biological response of body to harmful stimuli, such as pathogens, physical injury or damaged cells. The first four cardinal signs of inflammation -redness (Latin rubor), heat (calor), swelling (tumor), and pain (dolor) -have been known since ancient times and were described by Celsus (1st century AD). The fith sign, the loss of function, was added by Virchow in the 19th century (1870). Redness is caused by the vasodilation in the affected area, heat reflects the increased blood flow, swelling or edema is caused by the accumulation of fluids and the pain results from the edema, and it is also induced by chemical mediators. Finally, loss of function may be a consequence of pain and swelling.
There are two fundamental types of inflammation: acute or chronic. Acute inflammation is a short-term process which is characterized by a vascular response and initial recruitment of polymorphonuclear granulocytes, typically neutrophils, followed by monocytes, which differentiate locally into macrophages. This leads to a coordinate activation of various signaling pathways that regulate expression of both pro-and anti-inflammatory mediators including chemokines, cytokines, vasoactive amines, eicosanoids and products of proteolytic cascades. Briefly, after a tissue is injured, there is an increase of blood flow into the area (vasodilation), following by an increased permeability of the capillaries that permit plasma proteins and leukocytes to leave the circulation (extravasation). Circulating leukocytes *Address correspondence to this author at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain; Tel: (34) 91-4531200; Fax: (34) 91-4531208; E-mail: shortelano@cnic.es adhere to the endothelium via adhesion molecules, transmigrate across the endothelium, and migrate to reach the site of injury, where they remove the stimulus and repair the tissue.
Once inflammation has accomplished its function must be actively terminated to prevent unnecessary damage to tissues. Resolution of inflammation initiates in the first few hours after an inflammatory response begins and is mainly mediated by tissue-resident and recruited macrophages [1] . This active and coordinated program of resolution is controlled by endogenous 'pro-resolving' mediators such as lipoxins generated from arachidonic acid (AA), together with resolvins and protectins [2] [3] [4] .
If the inflammatory process persists, chronic inflammation takes place. Indeed, chronic inflammation might be defined as a prolonged, dysregulated and maladaptive response that results in cellular destruction, and is associated with many chronic human conditions and diseases, including asthma, atherosclerosis, cancer, and autoimmune diseases. The hallmark of chronic inflammation is the infiltration of mononuclear immune cells (monocytes, macrophages, lymphocyres, and plasma cells). These cells are recruited from the circulation by the steady release of chemotactic factors.
ROLE OF TRANSCRIPTION FACTOR NF-B IN INFLAMMATION
One of the most important regulators of immune system and inflammatory response is the nuclear transcription factor B (NF-B) [5] . NF-B is an ubiquitous transcription factor, evolutionarily conserved from flies to mammals [6] . NF-B regulates the transcription of a number of genes involved in programmed cell death (apoptosis), cell adhesion, proliferation, immune and inflammatory pathways, cellular stress response and tissue remodelling [7] [8] [9] [10] [11] [12] [13] . Table 1 shows a list of genes whose expression is regulated by NF-B.
Dysregulation of NF-B contributes to a variety of pathological conditions such as septic shock, acute inflammation, viral replication, and some malignancies [13, 14] (Table 2) . Hence, the extensive involvement of NF-B activation in human inflammation and disease establishes this transcription factor as a relevant target for the pharmacological activity of anti-inflammatory molecules. Indeed, there is a growing interest in the search for molecules that inhibit activation of NF-B.
In mammalian cells, there are five NF-B family members, RelA/p65, RelB, c-Rel, p50/p105 (NF-B1) and p52/p100 (NF-B2). NF-B is composed of homo-and heterodimers of different Rel family proteins but the most abundant and active forms of NF-B in many cell types are dimeric complexes of p50/RelA (p50/p65). All NF-B subunits share a Rel homology domain (RHD) of approximately 300 amino acids, that contains a nuclear localization sequence (NLS) and is involved in dimerization, sequencespecific DNA binding and interaction with the inhibitory I B proteins [15] . p65, RelB, and c-Rel, are synthesized as active proteins, contain a terminal transactivation domain (TAD) at their C-terminal end which is required for the activation of transcription [16] . On the other hand, p50 and p52, are generated through a C-terminal proteolytic processing of longer precursors, NF-B1 (p105) and NF-B2 (p100) respectively and lack TAD which therefore means that they are transcriptionally inactive and they have to form hetero-complexes with other members of this family to transactivate defined target genes [16] .
In unstimulated cells, NF-B is sequestered in the cytoplasm by association with the inhibitory proteins I B (I B , I B , I B , I B , Bcl3) that mask its NLS [7] . In response to an extracellular signal (e.g., inflammatory cytokines, mitogens, bacterial products, or oxidative stress), I B is phosphorylated by I B kinases (IKKs) at specific serine residues. The phosphorylation is followed by Lys 48 -linked (Ub K48 ) polyubiquitination of I B, which marks the protein for degradation by the 26S proteasome [15] . Degradation of I B allows the NF-B to translocate to the nucleus, where it binds to the promoter region of various genes, including cytokines [e.g., tumor necrosis factor (TNF)-, interleukin (IL)-1 ], cyclooxygenase-2 (COX-2), inducible nitric oxidesynthase (NOS-2), proteases [e.g., matrix metalloproteases (MMPs)], and receptors involved in leukocyte adhesion and migration [15] (Fig. 1) . Two major signaling pathways lead to activation of NF-B, the classical or canonical and the alternative pathway (Fig. 2) . Both pathways converge on the degradation through the proteasome pathway of the inhibitory molecules, but are triggered by different stimuli, and signal through a different IKK complex. In the classical canonical pathway, various signals including proinflammatory cytokines such as TNFand IL-1 and activation of Toll-like receptors (TLRs) cause the activation of an IKK complex consisting of the catalitic subunits IKK and IKK and the IKK regulatory subunit (also known as NF-B essential modulator, NEMO) [7] . The activated IKK complex then phosphorylates I B at 2 [15] . This pathway is crucial for the activation of innate immunity and inflammation as well as inhibition of apoptosis. An alternative pathway that is involved in B-cell activation, lymphoid organogenesis, and humoral immunity, is activated by different stimuli, such as lymphotoxin-(LT ) [17] , B-cell-activating factor (BAFF) [18] and CD40L [19] . This pathway is strictly dependent on IKK homodimers that are activated by the NF-B-inducing kinase (NIK) [17] and results in the processing of the cytosolic NF-B2/p100 precursor to yield the mature p52 subunit, followed by translocation of p52 to the nucleus [8, 20] .
NATURAL PRODUCTS AS A SOURCE OF NEW THERAPEUTIC AGENTS: TERPENOIDS
Bioactive natural products can be considered very promising starting points for the development of new therapeutic agents. Indeed, synthetic medicinal chemistry has not replaced natural products as essential components of our therapeutic arsenal and many of the medicines prescribed today are natural products. Drugs such the antimalarial artemisin and quinine, digoxin (widely used in the treatment of various heart conditions), the anticancer taxol, the analgesics codeine, morphine and acetylsalicylic acid, among others have been developed from natural products, which demonstrates that natural products has a dominant role in the discovery of leads for the development of drugs for the treatment of human diseases [21, 22] .
One of the most important families of natural compounds known for their medicinal value is the terpenoids. A few of them have been used for therapeutic purposes for centuries as antibacterial, anti-inflammatory, antitumoral agents but in recent decades the level of research activity on these compounds has continuously increased.
Terpenoids are the largest and most widespread class of secondary metabolites, mainly in plants and lower invertebrates. These compounds are found in higher plants, mosses, liverworts, algae and lichens, as well as in insects, microbes or marine organisms. Terpenoids are derived from a common biosynthetic pathway based on mevalonate as parent, and are named terpenoids, terpenes or isoprenoids with the subgroup of steroids among them as a class [23] [24] [25] [26] . In general, the term terpene is used to denote compounds containing an integral number of C5 units and chemically all terpenoids can be considered to be derived from the basic branched C5 unit isoprene (2-methyl-1,3-butadiene). It is useful to classify terpenoids according to the number of such C5 units present in the molecule, from which they are biogenetically derived. Thus, terpenoids are classified into hemi-, mono-, sesqui-, di-sester-, tri-and tetraterpenoids (carotenoids) having 1, 2, 3, 4, 5, 6 and 8 isoprenoid C5 residues, respectively.
In a previous review [27] , we have reported the chemical features and biosynthesis pathways of terpenoids. Diterpenoids containing four isoprene units (C-20) constitute a large group of compounds found in higher plants, fungi, insects and marine organisms. Most of the diterpenoids found in recent years have been isolated from Asteraceae and Lamiaceae, and this class of terpenoids has one of the widest ranges of biological activities. Diterpenoids are classified according to their chemical structure [27] in labdanes, pimaranes, abietanes, kauranes, taxanes, etc.
TERPENOIDS AS MODULATORS OF NF-B SIG-NALING PATHWAYS
With the continuous emergence of new diseases, development of new drugs is needed. In the last years, an extensive literature on different types of diterpenoids has been published, describing their pharmacological potential. Several biological actions have been reported for diterpenes including antibacterial, antifungal, anti-inflammatory, antileishmanial, cytotoxic and antitumour activities [28] . Since the description by Kopp and Ghosh (1994) [29] of sodium salicylate and its semi-synthetic derivative as the first plantderived NF-B inhibitor, a large number of terpenoids have been tested for NF-B inhibitory properties.
The molecular cascade of signaling events involved in NF-B activation, provides several steps for specific inhibition of NF-B activity. Inhibition of NF-B activation can occur by different mechanisms including (a) inhibiting the activation of IKK complex, (b) targeting the proteasomal degradation of or (c) interfering the translocation of NF-B to the nucleus, or the binding of NF-B to DNA. Several agents including natural products such as sesquiterpene lactones (helenalin) [30] [31] [32] , structural relative of flavonoids (caffeic acid phenethyl ester) [33] , sesterterpenes (cyclolinteinone) [34] , ent-kaurane diterpenes (oridonin and ponicidin) [35] and prostaglandins (15-deoxi-prostaglandin J 2 ) [36] , have been shown to inhibit either nuclear translocation of p65 or binding of NF-B to DNA. On the other hand, classic anti-inflammatory compounds such as salicylates and glucocorticoids either prevent the degradation of I B [29] or activate the transcription of I B [37] . Moreover, some naturally occurring inhibitors of ubiquitin-proteasome such as lactacystin, a streptomyces metabolite can block NF-B activation by preventing I B degradation [38] . Nevertheless, the most effective and selective approach for the inhibition of NF-B activation is provided by inhibitors of the IKK activity [30, 31] . Benzoquinones such as herbimycin A and geldanamycin isolated from marine and terrestrial bacteria [39] , sesquiterpene lactones such as parthenolide [30, 40] , kaurane diterpenes such as kamebakaurin [41] ; and labdane diterpenes such as hispanolone derivatives [42] are examples of the specifically targeting of IKK kinase activity.
BIOLOGICAL ACTIVITY OF DITERPENOIDS RE-LATED TO NF-B INHIBITION
Labdane Diterpenoids: Andalusol, Andrographolide, Hispanolone-Derived Labdanes, Pinusolide Labdane-type diterpenes have been reported to have broad spectrum of biological activities: antimicrobial, cytotoxic, anti-inflammatory, antiviral, antiprotozoal… [28, [42] [43] [44] . These diterpenes have been found as secondary metabolites in tissues of fungi, insects, marine organisms, and in essential oils, resins and tissues of higher plants. Examples of diterpenes reported in the literature as NF-kB inhibitors are described below, with special emphasis on their mechanism of action.
Andalusol
Andalusol is a naturally occurring labdane-type diterpene, isolated from Sideritis foetens (Lamiaceae). This compound exhibited anti-inflammatory activity when evaluated in in vivo models of paw and ear inflammation [45] . Andalusol also inhibited expression of NOS-2 protein by inhibition of NF-B activation in murine macrophage cell line J744. It inhibited the degradation of I B favouring the retention of the inactive NF-B complexes in the cytosol. The exact inhibitory mechanism was not verified, but andalusol might inhibit a step leading to the activation of the IKK, or possibly the IKK itself, but further work is required to address this question [46] .
Andrographolide
Andrographis paniculata is a shrub belonging to the Acanthaceae family, commonly used as a folk remedy for alleviation of inflammatory disorders in Asia for millennia. It currently is a prescribed medicine for treatment of rheumatoid arthritis in China. Andrographolide, a labdane diterpenoid isolated from this plant and related compounds have been investigated for their pharmacological activities in several animal studies, showing antipyretic and antiinflammatory activity. Andrographolide has been shown to inhibit the production of TNF-and IL-12 in lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages [47] . Inhibition of NF-B activation was described for andrographolide [48] . Mechanistically, it formes a covalent adduct with reduced cysteine (62) of p50, thus blocking the binding of NF-B oligonucleotide to nuclear proteins [48] . Andrographolide suppressed the activation of NF-B in stimulated endothelial cells, which reduced the expression of cell adhesion molecule E-selectin and prevented E-selectinmediated leukocyte adhesion under flow [49] . It also abro-gated the cytokine-and endotoxin-induced peritoneal deposition of neutrophils, attenuated septic shock, and prevented allergic lung inflammation in vivo [48] . Notably, it had no suppressive effect on I B degradation, p50 and p65 nuclear translocation, or cell growth rates.
Hispanolone-Derived Labdanes
Giron et al. (2007) [42] evaluated a series of 11 labdanetype diterpenoids with various patterns of substitution, consisting of the natural diterpenoids hispanolone and galeopsin and a series of nine hispanolone derivatives (2-8, 10 and 11) as potential anti-inflammatory agents. Two of these diterpenoids (dehydroisohispanolone and 8,9-dehydrohispanolone-15,16-lactol) reduced the production of nitric oxide (NO), prostaglandin E 2 (PGE 2 ), and TNF-in LPS-activated murine RAW 264.7 macrophages, with IC 50 in the range 1-10 μM. Inhibition of these inflammatory mediators was related to inhibition of the expression of NOS-2 and COX-2 at the transcriptional level. The inhibition by both compounds of LPS-induced I B degradation, p65 nuclear translocation, and IKK activity indicates that their anti-inflammatory actions are at least partially mediated by inhibition of NF-Bdependent gene transcription. Furthermore, the effects of these diterpenoids on MAPK signaling suggest that these kinases might participate in the transduction of the LPS signal to the IKK complex.
Pinusolide
Pinusolide, a labdane-type diterpene lactone isolated from Biota orientalis was found to be a potent anti-PAF receptor binding antagonist. Choi et al., [50] studied the inhibitory effect of 15-methoxypinusolidic acid (15-MPA) isolated also from Biota orientalis (Cupressaceae) on LPS-induced inflammation in murine microglial BV2 cells. 15-MPA significantly reduced the expression and activity of NOS-2, and the production of NO in LPS-stimulated BV2 cells. In addition, 15-MPA significantly suppressed the expressions of TNF-, IL-6, and COX-2. However, 15-MPA did not affect LPS-induced degradation of I B-and translocation of NF-B into the nucleus. LPS-activated p38 MAPK, ERK-1/2, and JNK were not affected by 15-MPA. Taken together, this study demonstrates that 15-MPA inhibits LPS-induced NOS-2 expression and NO production, independent on MAPK and NF-B.
Hypoestoxide
Hypoestoxide (a bicyclo [9, 3, 1] pentadecane) is a diterpene from Hypoestes rosea, a tropical shrub in the family Acanthacea, several members of which are used in folk medicine in Nigeria. It was demonstrated that hypoestoxide abrogates the production of pro-inflammatory cytokines (IL-1 , IL-6, and TNF-) in LPS-activated normal human peripheral blood mononuclear cells [51] . Moreover, hypoestoxide inhibits the production of NO by IL-1 -or IL-17-stimulated normal human chondrocytes [51] . In vivo, oral administration of hypoestoxide to mice significantly ameliorated hind paw edema induced by antibodies to type II collagen plus LPS. Furthermore, topical administration of this compound to mice also significantly inhibited phorbol esterinduced ear inflammation. The anti-inflammatory activity of hypoestoxide may be due in part to its ability to inhibit NF-B activation through direct inhibition of IKK activity [51] .
Antiogenic and antitumor activities have also been reported for this byciclic diterpenoid [52] .
Tanshinone IIA Tanshinone IIA, a diterpene isolated from Salvia miltiorrhiza reduced the production of pro-inflammatory mediators in RAW 264.7 cells stimulated with LPS. Jang et al. (2006) [53] investigated the inhibitory effects of tanshinone IIA on the activation of NF-B and I B phosphorylation, and also examined phosphorylation of NIK and IKK as well as the activation of MAPKs such as p38 MAPK (p38), extracellular signal-regulated kinases 1/2 (ERK1/2), and cJun N-terminal kinase (JNK) in RAW 264.7 cells stimulated with LPS. Tanshinone IIA inhibited NF-B-DNA complex, NF-B binding activity, and the phosphorylation of I B in a dose dependent manner. Tanshinone IIA also inhibited the translocation of NF-B from cytosol to nucleus. Moreover, the phosphorylation of NIK and IKK as well as the phosphorylation of p38, ERK1/2, and JNK in the LPS-stimulated RAW 264.7 cells were suppressed by this compound in a dose-dependent manner. These results suggest that tanshinone IIA may inhibit LPS-induced I B degradation and NF-B activation via suppression of the NIK-IKK pathway as well as the MAPKs (p38, ERK1/2, and JNK) pathway in RAW 264.7 cells and these properties may provide a potential mechanism that explains the anti-inflammatory activity of tanshinone IIA.
More recently, Xu et al. [54] evaluated the effect of sodium tanshinone IIA sulfonate (STS), a water-soluble derivative of tanshinone IIA, on concanavalin A (ConA)-induced hepatitis (CIH) in mice, an experimental model of immunemediated liver injury. C57BL/6 mice pretreated with STS released much less alanine transaminase into plasma in response to ConA challenge and had reduced inflammatory infiltration and hepatocyte apoptosis in the liver compared with control mice pretreated with vehicle solutions. Thus, STS protected mice from CIH. In STS-pretreated mice induced with CIH, we found abrogated TNF-and interferon-(IFN-) production. Moreover, mRNA expressions of IFNinducible protein-10 and macrophage inflammatory protein-1 in these mice were decreased. The mechanism of antiinflammatory effects of STS may be attributed to its modulation of crucial inflammatory signaling pathways, including NF-B and IFN-/STAT1. In conclusion, STS was capable of protecting mice from immune-mediated liver injury in vivo, and the protection was associated with its suppressive effect on the production of important inflammatory mediators through modulating NF-B and IFN-/STAT1 signaling pathways.
Pimarane Diterpenoids

Acanthoid Acid
The acanthoic acid is a pimarane diterpene that was isolated from the root bark of Acanthopanax koreanum Nakai (Araliaceae). Crude extracts of this plant have been used in traditional Korean medicine as a tonic and sedative, as well as a remedy for the treatment of rheumatism. Studies revealed that this compound suppresses the production of IL-1 and TNF-at 10 mg/mL, is orally active and has no significant toxicity in a rodent model of chronic inflammation. A series of 16 non-natural acanthoic acid analogs was devel-oped by Lam et al. [55, 56] , and were described as modulators of several proinflammatory cytokines such as TNF-, IL-1 and IL-6 in human peripheral blood mononuclear cells and murine RAW 264.7 macrophages. Further studies, through EMSA and Western blot analyses, indicated that these compounds exert their anti-inflammatory profile by inhibiting NF-B-mediated cytokine synthesis [56] .
Moreover, these diterpenes have also been described to be potent activators of liver X receptors (LXR and LXR ) in murine macrophages [57] . LXRs are nuclear receptors that play central roles in the transcriptional control of lipid metabolism and modulate immune and inflammatory responses. Indeed, LXRs repress a set of inflammatory genes after bacterial, LPS, TNF-, or IL-1 stimulation [58] , including NOS-2 and COX-2, IL-6 and IL-1 , the chemokines monocyte chemoattractant protein-1 (MCP-1) and MCP-3, and MMP9, through a mechanism that involved inhibition of the NF-B pathway [58, 59] .
Abietane Diterpenoids: Carnosol and Carnosic Acid
Carnosol and Carnosic Acid
Carnosol and carnosic acid are abundant abietane diterpenes with aromatic ring C constituents in Rosemary extracts (Rosmarinus officinalis). Biological activities as antioxidant and anticarcinogen have been described for carnosol and carnosic acid [60, 61] . In addition, carnosol has also antiinflammatory properties. Carnosol is able to inhibit NOS-2 expression and reduced LPS-stimulated NO production by inhibiting NF-B activation in mouse macrophage RAW 264.7 cell line in B16/F10 mouse melanoma cells [62] . Moreover, carnosol also inhibited LPS-induced p38 and ERK activation.
Kauranes: Foliol, Linearol, Siegeskaurolic Acid, EntKaurane, Diterpenoids from Croton Tonkinensis, Diterpenoids from Isodon Species Kaurane diterpenoids represent an important group of tetracyclic diterpenes. Diverse biological activities have been described for this type of diterpenoids, including plant growth regulating, antimicrobial, antiparasitic, insect antifeedant, cytotoxic, antitumour, anti-HIV, hipotensive and anti-inflammatory activities, among others [63] . More recently, attention has been paid to the study of the biological effects of tetracyclic ent-kaurane diterpenoids, because the number of these molecules isolated and characterized is continuously increasing [64] ; Ent-kaurane is the main diterpene intermediate involved in the biosynthesis of gibberellins, a widespread family of plant hormones with isoprenoid structure that control various physiological plant functions as growth, germination and flowering [65] .
Foliol and Linearol
Kaurenoic acid is one of the intermediate compounds involved in the biosynthesis of diverse kaurane diterpenes. Two kaurene diterpenes named foliol, linearol, hydroxylated molecules derived from the ent-kaur-16-en-19-oic acid (kaurenoic acid), and kaurenoic acid were reported as inhibitors of NF-B pathway in macrophages [66] . These compounds inhibit the expression of NOS-2 and the release of TNF-in murine J774 macrophages challenged with LPS. These diterpenes inhibit NF-B and IKK activation in vivo but failed to affect in vitro the function of NF-B, the phosphorylation and targeting of I B , and the activity of IKK . Transient expression of NIK activated the IKK complex and NF-B, a process that was inhibited by kaurenes, indicating that the inhibition of NIK was one of the targets of these diterpenes. These results show that kaurenes impair the inflammatory signaling by inhibiting NIK, a member of the MAPK kinase superfamily that interacts with TNF receptorassociated factors, and mediate the activation of NF-B by these receptors. Moreover, kaurenes delayed the phosphorylation of p38, ERK1, and ERK2 MAPKs, but not that of JNK, in response to LPS treatment of murine J774 cells. The absence of a coordinate activation of MAPK and IKK might contribute to a deficient activation of NF-B that is involved in the anti-inflammatory activity of these molecules.
Siegeskaurolic Acid
Park et al. [67] reported the anti-inflammatory activity of the diterpene ent-16 ,17-hydroxy-kauran-19-oic acid (siegeskaurolic acid) isolated from Siegesbeckia pubescens root. Pretreatment with siegeskaurolic acid (20 or 30 mg/kg/day, p.o.) exhibited anti-inflammatory and antinociceptive effects in animal models as acetic acid-induced abdominal constriction and hot plate tests in mice. Siegeskaurolic acid was also found to significantly inhibit the productions of NO, PGE 2 , and TNF-in murine RAW 264.7 macrophages. Consistent with these findings, NOS-2 and COX-2 proteins, and NOS-2, COX-2, and TNFmRNAs were found to be inhibited by siegeskaurolic acid. Furthermore, siegeskaurolic acid inhibited NF-B activation induced by LPS, and this was associated with the prevention of I B degradation, and subsequently with decreased nuclear p65 and p50 protein levels. The anti-inflammatory and antinociceptive properties of siegeskaurolic acid may be due to NOS-2, COX-2 and TNF-inhibition via the downregulation of NF-B binding activity.
Ent-Kaurane Diterpenoids from Croton Tonkinensis
Four ent-kaurane diterpenoids isolated from the leaves of Croton tonkinensis have been recently described to be potent inhibitors of NO release. These ent-kauranoids, strongly inhibited the LPS-induced activation of NO production in murine RAW 264.7 macrophage cell line in a dose dependent manner. Moreover, these compounds inhibited NF-B activation with an IC 50 value in the range 0.07-0.42 μM. Although the exact mechanism involved in the NF-B inhibition was not described, authors speculated that the presence of reactive centers, such as an exomethylene group conjugated to a carbonyl group in the cyclopentanone ring, may be the responsible of NF-B inhibition [68] .
Diterpenoids from Isodon Species
Oridonin, Ponicidin, Kamebanin, Kamabecetal, Kamebakaurin, Excisanin A and Inflexinol Isodon species are an important source of bioactive diterpenoids [69] . The use of Isodon species in Chinese popular folk medicine has a long tradition for the treatment of respiratory and gastrointestinal bacterial infections, inflammation and cancer. In 1977, the standard extract of I. rubescens leaves was successfully developed into a drug product which was used in treating sore throats and inflammation in China. Isodon diterpenoids have attracted considerable attention as antibacterial, antitumour, anti-inflammatory, and antifeeding agents. Many natural Isodon diterpenoids from different species, as well as hemisynthetic derivatives have been tested as anti-inflammatory agents. Ent-kauranes is the largest group of known Isodon diterpenoids, and appears to be the most widely distributed.
Oridonin and Ponicidin
Oridonin (epoxy-ent-kaurane) and ponicidin, the two major constituents of I. rubescens have been the most frequently studied compounds among Isodon diterpenoids. More recently, ent-kauranes isolated from I. rubescens including oridonin, ponicidin and xindongnin A, were found to be potent inhibitors of NF-B transcription activity and the expression of its downstream targets, COX-2 and NOS-2 in murine RAW 264.7 macrophage cell line. The mechanisms of action of diterpenoids against NF-B are similar, but significant differences were also identified. All of the diterpenoids directly interfere with the DNA-binding activity of NF-B to its response DNA sequence [35] . Oridonin and ponicidin have an additional impact on the translocation of NF-B from the cytoplasm to nuclei without affect I Bphosphorylation and degradation. The effects of these compounds on the interaction of NF-B with consensus DNA sequence are unique. Different inhibitory effects were observed when NF-B bound to various DNA sequences. Both p65/p65 and p50/p50 homodimers, as well as p65/p50 heterodimer association with their responsive DNA, were inhibited.
Kinetic studies on the NF-B DNA interaction indicate that the diterpenoids decrease the B max app but had no effect on K d app . This suggest that this class of compounds interacts with both p65 and p50 subunits at a site other than the DNA binding site and subsequently modulates the binding affinity of the transcription factor toward DNA with different NF-B binding sequences. Ent-kaurenoids are a novel and new class of NF-B inhibitors that interfere with the binding between NF-B and DNA with a unique sequence by a distinct mechanism [35, 69] .
Kamebanin, Kamabecetal, Kamebakaurin and Excisanin A
Plant extracts of Isodon japonicus, contain several highly oxidized kaurane diterpenoids as kamebanin, kamabecetal, kamebakaurin and excisanin A. It was found that all diterpene compounds inhibited LPS-induced DNA-binding activity of NF-B dose-dependently and NF-B activation was completely inhibited in the presence of 10 μg/ml of kamebakaurin or excesanin A [41, 70] . Lee et al. [41] deeply investigated the mechanism of action of kamebakaurin, describing this diterpene as a potent inhibitor of NF-B activation by directly targeting targeting DNA-binding activity of p50. Kamebakaurin prevented the activation of NF-B by different stimuli in various cell types including murine RAW 264.7 macrophage cell line, human MCF-7 breast cancer cell line, human Jurkat T leukemia cells, and human monocytic THP-1 cell line. Kamebakaurin did not prevent either stimuli-induced degradation of I B-or nuclear translocation of NF-B, however, it significantly interfered DNA binding activity of activated NF-B in cell and in vitro and preferentially prevented p50-mediated DNA-binding activity of NF-B rather than that of RelA as measured using in vitro translated p50 and RelA proteins. Moreover, a p50 mutant with a Cys-62 --> Ser mutation was not inhibited with kamebakaurin, indicating that the effect of kamebakaurin was probably due to its interaction with cysteine 62 in p50. The covalent modification of p50 by kamebakaurin was further demonstrated by mass spectrometry analysis that showed an increase in the molecular mass of kamebakaurin-treated p50, and this modification was not reverted by addition of dithiothreitol. These results suggested that kamebakaurin exhibited its inhibitory activity by a direct covalent modification of cysteine 62 in the p50. Also, treatment of cells with kamebakaurin prevented TNF--induced expression of antiapoptotic NF-B target genes encoding c-IAP1 (hiap-2) and c-IAP2 (hiap-1), members of the inhibitor of apoptosis family, and Bfl-1/A1, a prosurvival Bcl-2 homologue, and augmented the TNF--induced caspase 8 activity, thereby resulting in sensitizing MCF-7 cells to TNF--induced apoptosis. Furthermore, kamebanin, kamebacetal and kamebakaurin also significantly inhibited LPS-induced NO and PGE 2 production but they did not influence the DNA binding of AP-1.
Inflexinol
Inflexinol, an ent-kaurane diterpenoid, was isolated from the leaves of Isodon excisus [71] . Inflexinol (1, 5, 10 μM) suppressed the expression of NOS-2 and COX-2 as well as the production of NO in LPS-stimulated RAW 264.7 cells and astrocytes. Consistent with the inhibitory effect on NOS-2 and COX-2 expression, inflexinol also inhibited transcriptional and DNA binding activity of NF-B via inhibition of I B degradation as well as p50 and p65 translocation into nucleus. These results suggest that inflexinol inhibits NOS-2 and COX-2 expression through inhibition of NF-B activation, thereby inhibits generation of inflammatory mediators in RAW 264.7 cells and astrocytes.
Triptolide
In recent years there has been considerable interest in the use of Tripterygium extracts and of the main bioactive constituent, triptolide to treat a variety of autoimmune and inflammation-related conditions, such rheumatoid arthritis. Intensive medicinal research [72] have attempted to identify the target molecule(s) and understanding its mechanisms [73] . The main mode of action of the Tripterygium extracts and triptolide is the inhibition of expression of proinflammatory genes such as those for IL-2, NOS-2, TNF-, COX-2 and IFN-. The efficacy and safety of certain types of Tripterygium extracts were confirmed in human clinical trials in the US and abroad. Triptolide is a naturally occurring diterpene triepoxide whose anti-inflammatory effects correlate with transcriptional inhibition of various cytokines. Several studies [74] have verified inhibition of NF-B activation by triptolide in different cell types including human alveolar basal epithelial A549 cells and human Jurkat T leukemia cells [75] . In RAW 264.7 cells stimulated with LPS to mimic inflammation, triptolide inhibits NO production in a dosedependent manner and abrogates NOS-2 gene expression. The mechanism by which triptolide inhibits murine NOS-2 gene expression was analyzed by examining activation of MAPK and NF-B in these cells. Addition of triptolide inhibited phosphorylation of JNK but not that of ERK or p38 MAPK. In addition, triptolide significantly inhibited the DNA binding activity of NF-B, suggesting that triptolide acts to inhibit inflammation through inhibition of NO pro-duction and NOS-2 expression through blockade of NF-B and JNK activation. Triptolide is also a potent inhibitor of NF-B activation in T lymphocytes and this effect is partly due to the upregulation of I B mRNA expression [74] .
Triptolide bound specifically and irreversibly to a single, 90 kDa protein in nuclear extracts from stimulated and nonstimulated monocytic and epithelial cell lines. Thiol reactivity of one or more of the epoxides on triptolide was necessary for the covalent binding. The correlation between the structure-activity relationship and observed binding suggests that identification of the triptolide binding protein could provide insight into the cellular mode of action of this antiinflammatory natural product [76] .
Pepluane Diterpenoids
From the whole plant of Euphorbia peplus L., a diterpene based on a rare pepluane skeleton, named pepluanone was isolated, and the ability of this compound to act as antiinflammatory agent has been evaluated by in vivo tests on carrageenin-induced rat paw edema, an experimental model of acute inflammation. In vitro experiments performed on pepluanone allowed to hypothesize that its activity could be explained in reducing the production of NO, PGE 2 , and TNF-by inhibiting the expression of NOS-2, COX-2, and TNF-mRNA through the down-regulation of NF-B binding activity [77] .
Marine Diterpenoids
Natural products isolated from marine organisms have also been shown a great potential in drug discovery. For several decades, marine organisms have provided marine natural products chemists with a rich source of unsual metabolites [78] [79] [80] [81] .
Paya et al. [82] described the inhibitory effect of a series of 6 cycloamphilectenes, novel marine diterpenes based on amphilectene skeletons and isolated from the Vanuatu sponge Axinella sp., on NO, PGE 2 and TNF-production in murine peritoneal macrophages. These compounds reduced Fig. (3) . Main signaling pathways inhibited by diterpenoids.
potently NO production in a concentration-dependent manner with IC 50 values in the submicromolar range (0.1-4.3 μM). Studies on intact cells and Western blot analysis showed that the more potent cycloamphilectenes reduced the expression of NOS-2 without affecting COX-2 expression. Among them cycloamphilectene 2, the unique compound bearing an exocyclic methylene group, was able to reduce NO production without affecting TNF-release. Cycloamphilectene 2, which is an inhibitor of the nuclear factor-B pathway, exhibited topical anti-inflammatory activity.
CONCLUSION REMARKS
Since the discovery of NF-B as a key transcription factor in the inflammatory response, inhibition of NF-B activation has constituted a promising therapeutic approach to fight against many of the human inflammatory pathologies including arthritis, asthma, the auto-immune diseases and different types of cancer. Consistent with this, several commonly-used anti-inflammatory agents such as aspirin (sodium salicylate), and glucocorticoids have been shown to inhibit NF-B activity. Natural products are very promising candidates for drug development. In addition, the therapeutic effects of many natural products as anti-inflammatory agents may be due to their ability to inhibit NF-B-dependent inflammation. From an evolutionary point of view, plants produce secondary metabolites such as terpenoids as a mechanism of defence against pathogen attack. Similar to animal immune responses, induced plant defence responses involve a network of signal transduction and the rapid activation of gene expression following pathogen infection. Terpenoid release could be envisaged as a way of combating pathogens through the destruction of the immune system after NF-B signaling suppression. This phenomenon may also provide effective therapeutic compounds for the treatment of inflammatory diseases and cancer in humans. In this review we have highligthed the potential of diterpenoids as potent and pathway-specific modulators of NF-B pathways.
The better understanding of the mechanisms that govern NF-B pathway, has contributed to the development of inhibitors that block NF-B activation. Over 750 inhibitors of the NF-B pathway have been identified, including a variety of natural and synthetic molecules that can act either directly on IKKs, on the proteosome machinery, or on the NF-B-DNA binding [83] . However, regulation of IKK complex has been the prime target for the development of NF-B signaling inhibitors. Indeed, a vast majority of diterpenoids described in this review exert their inhibitory effects signaling at this step (Fig. 3) . Noteworthy, a great number of diterpenoids that potently inhibit NF-B, bear --unsaturated carbonyl functions which are widely recognized as the most common NF-B inhibitory pharmacophore. Methylene groups of --unsaturated carbonyl compounds can react by Michael type addition to sufhydryl groups of cysteine residues in the DNA binding domain of NF-B subunit [81] .
There is no doubt that further studies remain necessary to fully understand the molecular mechanisms induced by diterpenoids as NF-B inhibitors, however it could be concluded that diterpenoids are very promising candidates as leads for developing useful therapeutics. 
